Literature DB >> 31235151

Relationship between insulin resistance, metabolic syndrome components and serum uric acid.

Endy Adnan1, Ilham Akbar Rahman2, H P Faridin1.   

Abstract

BACKGROUND: Metabolic syndrome is cluster of abnormality related with increasing cardiovascular events. Hyperuricemia is level of uric acid more than 7 mg/dL for men. Some research have reported relation between metabolic syndrome mediated by insulin resistance with increasing of serum uric acid level.
OBJECTIVE: Assess relationship between insulin resistance and metabolic syndrome components with the level of serum uric acid.
METHOD: Observational study with cross sectional approach conducted on 102 outpatient subjects at Dr. RSUP Wahidin Sudirohusodo (RSWS) hospital and Hasanuddin University Hospital in the period of July-September 2018.
RESULTS: Subjects with IR were found to be significantly higher for having MetS (88.23% vs. 11.77% p = 0,000). In subjects with IR, the average serum uric acid level was higher compared to non-IR subjects, but this difference was not significant (6.63 vs 6.42 mg/dL; P = 0.325). In subjects with MetS, the average serum uric acid level was higher compared to subjects with non-MetS but this difference was not significant (6.62 vs. 6.28 mg/dL; P = 0.556). No significant relationship was found between IR and MetS with serum uric acid level.
CONCLUSION: Insulin resistance is related to the incidence of MetS and in both of these circumstances an independent tendency is found to increase uric acid levels. The role of insulin resistance in the relationship between metabolic syndrome and uric acid levels was not proven in this study.
Copyright © 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Insulin resistance; Metabolic syndrome; Serum uric acid

Year:  2019        PMID: 31235151     DOI: 10.1016/j.dsx.2019.04.001

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  7 in total

1.  [Triglyceride-glucose product is an independent risk factor for predicting chronic kidney disease in middle-aged and elderly population: a prospective cohort study].

Authors:  X Xu; X Tang; H Che; C Guan; N Zhao; S Fu; L Liu; Y Ye; M Guo; H Min; D Zhen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-11-20

Review 2.  The Prevalence of Insulin Resistance in Malaysia and Indonesia: An Updated Systematic Review and Meta-Analysis.

Authors:  Lucky Poh Wah Goh; Suraya Abdul Sani; Mohd Khalizan Sabullah; Jualang Azlan Gansau
Journal:  Medicina (Kaunas)       Date:  2022-06-19       Impact factor: 2.948

3.  Triglyceride-Glucose Index for the Diagnosis of Metabolic Syndrome: A Cross-Sectional Study of 298,652 Individuals Receiving a Health Check-Up in China.

Authors:  Mingfei Jiang; Xiaoran Li; Huan Wu; Fan Su; Lei Cao; Xia Ren; Jian Hu; Grace Tatenda; Mingjia Cheng; Yufeng Wen
Journal:  Int J Endocrinol       Date:  2022-06-29       Impact factor: 2.803

4.  The Association Between Total Percent Fat and Serum Uric Acid in Adults.

Authors:  Juan Sun; Chenyang Yue; Zhen Liu; Jie Li; Weiming Kang
Journal:  Front Nutr       Date:  2022-05-20

5.  Uric acid lowering improves insulin sensitivity and lowers blood pressure: a meta-analysis of randomized parallel-controlled clinical trials.

Authors:  Qunchuan Zong; Guanyi Ma; Tao Wang
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

6.  Mediation effect of obesity on the association between triglyceride-glucose index and hyperuricemia in Chinese hypertension adults.

Authors:  Jin Sun; Mingyan Sun; Yongkang Su; Man Li; Shouyuan Ma; Yan Zhang; Anhang Zhang; Shuang Cai; Bokai Cheng; Qiligeer Bao; Ping Zhu; Shuxia Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-12-13       Impact factor: 3.738

7.  Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China.

Authors:  Rui Huang; Zi Cheng; Xingyi Jin; Xuemin Yu; Jinhui Yu; Yunpeng Guo; Li Zong; Jie Sheng; Xing Liu; Sufang Wang
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.